COMPARISON OF HYPOMETHYLATING AGENTS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME: RETROSPECTIVE ANALYSIS, SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Unal, A. [1 ]
Keni, N. [1 ]
Yildizhan, E. [1 ]
Turak, E. [1 ]
Kaynar, L. [1 ]
Zararsiz, G. [1 ]
Uysal, E. [1 ]
Eser, B. [1 ]
Cetin, M. [1 ]
机构：
[1] Erciyes Univ, Dept Hematol, Kayseri, Turkey
来源：
LEUKEMIA RESEARCH | 2017年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP-22
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [31] Life after hypomethylating agents in myelodysplastic syndrome: new strategies
    Santini, Valeria
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (02) : 155 - 162
  • [32] INFECTIONS IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME ON TREATMENT WITH AZACYTIDINE: EXPERIENCE OF A SINGLE CENTER
    de Bonis, C.
    Lakhwani, S.
    Martin, A.
    Gonzalez, B.
    Iraheta, S.
    Hernandez, M. T.
    Hernandez-Nieto, L.
    Raya, J. M.
    HAEMATOLOGICA, 2014, 99 : 195 - 196
  • [33] Meta-analysis on hypomethylating agents in myelodysplastic syndromes
    Herbst, Christine
    Baner, Kathrin
    Kreuzer, Karl-Anton
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02): : 342 - 343
  • [34] Retrospective analysis of rapid drug desensitization with biologic agents: A single center experience
    Erkaya, Done Gulcin Unutmaz
    Durmaz, Makbule Seda Bayrak
    Akin, Begum Gorgulu
    Bavbek, Sevim
    CLINICAL AND TRANSLATIONAL ALLERGY, 2024, 14 (10)
  • [35] Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents
    Lee, Sangmin
    Mohan, Sanjay
    Knupp, Jessica
    Chamoun, Kamal
    de Jonge, Adrienne
    Yang, Fan
    Baloglu, Erkan
    Shah, Jatin
    Kauffman, Michael G.
    Shacham, Sharon
    Bhatnagar, Bhavana
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [36] Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na
    Seetharam, Mahesh
    Fan, Alice C.
    Tran, Mai
    Xu, Liwen
    Renschler, John P.
    Felsher, Dean W.
    Sridhar, Kunju
    Wilhelm, Francois
    Greenberg, Peter L.
    LEUKEMIA RESEARCH, 2012, 36 (01) : 98 - 103
  • [37] Treatment of Higher Risk Myelodysplastic Syndrome Patients Unresponsive to Hypomethylating Agents with ON 01910.Na
    Seetharam, Mahesh
    Tran, Mai
    Fan, Alice C.
    Xu, Liwen
    Renschler, John P.
    Felsher, Dean W.
    Sridhar, Kunju
    Wilhelm, Francois
    Greenberg, Peter L.
    BLOOD, 2010, 116 (21) : 1635 - 1635
  • [38] Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents
    Sangmin Lee
    Sanjay Mohan
    Jessica Knupp
    Kamal Chamoun
    Adrienne de Jonge
    Fan Yang
    Erkan Baloglu
    Jatin Shah
    Michael G. Kauffman
    Sharon Shacham
    Bhavana Bhatnagar
    Journal of Hematology & Oncology, 15
  • [39] Current status of pretransplant intensive chemotherapy or hypomethylating agents for myelodysplastic syndrome
    Niederwieser, Christian
    Kroeger, Nicolaus
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (04)
  • [40] Hematopoietic cell transplantation in Myelodysplastic Syndrome after Failure of Hypomethylating Agents
    Festuccia, M.
    Deeg, J.
    Scott, B.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S75 - S75
12345